Global Infectious Disease Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Infectious Disease Diagnostics Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Infectious disease diagnostics are medical tests and assays used to identify infectious agents, such as bacteria, viruses, and parasites, in patient samples. They play a crucial role in early detection and effective management of infectious diseases.
Global Infectious Disease Diagnostics market is projected to reach US$ 4776.2 million in 2029, increasing from US$ 3644 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2029. Demand from Hepatitis C and Hepatitis B are the major drivers for the industry.
The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Infectious Disease Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Bio Mérieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation
Segment by Type
Molecular Diagnostic Technique
Traditional Diagnostic Technique
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Infectious Disease Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Infectious Disease Diagnostics introduction, etc. Infectious Disease Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Infectious Disease Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Global Infectious Disease Diagnostics market is projected to reach US$ 4776.2 million in 2029, increasing from US$ 3644 million in 2022, with the CAGR of 4.3% during the period of 2024 to 2029. Demand from Hepatitis C and Hepatitis B are the major drivers for the industry.
The market for infectious disease diagnostics is driven by the increasing prevalence of infectious diseases and the need for accurate and rapid diagnostic solutions to control disease outbreaks. The market's growth is also influenced by technological advancements, such as molecular diagnostics and point-of-care testing.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Infectious Disease Diagnostics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Bio Mérieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation
Segment by Type
Molecular Diagnostic Technique
Traditional Diagnostic Technique
Segment by Application
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Infectious Disease Diagnostics market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Infectious Disease Diagnostics introduction, etc. Infectious Disease Diagnostics Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Infectious Disease Diagnostics market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices